John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 71,918 shares at $256.91 ($18.6M) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Seasonal sale ($18.6M) by Chief Executive Officer — this insider has traded BGNE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.91 | 3,500 | $899K | 4.8% |
| 2 | $256.91 | 3,500 | $899K | 4.8% |
| 3 | $257.92 | 13,598 | $3.5M | 18.8% |
| 4 | $257.92 | 13,598 | $3.5M | 18.8% |
| 5 | $258.91 | 8,200 | $2.1M | 11.4% |
| 6 | $259.77 | 6,705 |
| $1.7M |
| 9.3% |
| 7 | $259.77 | 6,705 | $1.7M | 9.3% |
| 8 | $261.08 | 2,906 | $759K | 4.1% |
| 9 | $261.08 | 2,906 | $759K | 4.1% |
| 10 | $262.03 | 3,400 | $891K | 4.8% |
| 11 | $262.03 | 3,400 | $891K | 4.8% |
| 12 | $262.97 | 1,700 | $447K | 2.4% |
| 13 | $262.97 | 1,700 | $447K | 2.4% |
| 14 | $264.27 | 100 | $26K | 0.1% |
| Total | $259.17 avg | 71,918 | $18.6M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |